Researchers use SARS-CoV-2 to bioengineer universal vaccine platform

15078

Sumary of Researchers use SARS-CoV-2 to bioengineer universal vaccine platform:

  • In the current study, the scientists developed a nanovaccine platform by bioengineering bacteriophage T4 using CRISPR technology.
  • They used severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a version to develop the platform.
  • To curb the viral transmission, several vaccines have been made in record moment, and some of these vaccines are already rolling out in many pandemic-affected countries.
  • For example, recombinant phage containing CoV-2 insert #1 (dark blue) can be used to infect CRISPR E.

Want to know more… click here go to source.

From -

Close

Languages